Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii

Veterinary Parasitology

Volumn 164, Issue 2-4, 2009, Pages 134-140

  Fang, Rui ^a   Nie, Hao ^a   Wang, Zhengsong ^a   Tu, Pan ^a   Zhou, Danna ^a   Wang, Lixia ^a   He, Lan ^a   Zhou, Yanqin ^a   Zhao, Junlong ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Conventional DNA vaccine; Protective immune response; Suicidal DNA vaccine; Toxoplasma gondii MIC3

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; MICRONEME PROTEIN 3; PARASITE ANTIBODY; POLYPEPTIDE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TOXOPLASMOSIS;

ANIMALS; GENES, PROTOZOAN; MICE; MICE, INBRED BALB C; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA; VIRULENCE;

MUS; TOXOPLASMA GONDII;

EID: 70249110018     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.06.012     Document Type: Article

References (32)

1. Alarcon J.B., Waine G.W., and McManus D.P. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv. Parasitol. 42 (1999) 343-410
2. Berglund P., Smerdou C., Fleeton M.N., Tubulekas I., and Liljeström P. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol. 16 (1998) 562-565
3. Bout D.T., Mevelec M.N., Velge-Roussel F., Dimier-Poisson I., and Lebrun M. Prospects for a human Toxoplasma vaccine. Curr. Drug Targets-Immune Endocr. Metab. Dis. 2 (2002) 227-234
4. Buxton D., Thomson K., Maley S., Wright S., and Bos H.J. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec. 129 (1991) 89-93
5. Cui Y.L., He S.Y., Xue M.F., Zhang J., Wang H.X., and YAO Y. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Parasite Immunol. 30 (2008) 309-313
6. Desolme B., Mevelec M.N., Buzoni-Gatel D., and Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18 (2000) 2512-2521
7. DiCiommo D.P., and Bremner R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J. Biol. Chem. 273 (1998) 18060-18066
8. Diab M.R., and El-Bahy M.M. Toxoplasma gondii: virulence of tachyzoites in serum free media at different temperatures. Exp. Parasitol. 118 (2008) 75-79
9. Doel T.R. Optimisation of the immune response to foot and-mouth disease vaccines. Vaccine 17 (1999) 1767-1771
10. Ferreira I.M., Vidal J.E., Costa-Silva T.A., Meira C.S., Hiramoto R.M., Penalva de Oliveira A.C., and Pereira-Chioccola V.L. Toxoplasma gondii: genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers. Exp. Parasitol. 118 (2008) 221-227
11. Fleeton M.N., Liljestrom P., Sheahan B.J., and Atkins G.J. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine. J. Gen. Virol. 81 (2000) 749-758
12. Girish M.B. Development of a vaccine for toxoplasmosis: current status. Microb. Infect. 5 (2003) 457-462
13. Guo H., Liu Z., Sun S., Bao H., Chen Y., Liu X., and Xie Q. Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China 99. Vaccine 23 (2005) 3236-3242
14. Gurunathan S., Klinman D.M., and Seder R.A. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18 (2000) 927-974
15. Hsu K.F., Hung C.F., Cheng W.F., He L., Slater L.A., Ling M., and Wu T.C. Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen. Gene Ther. 8 (2001) 376-383
16. Ismael A.B., Sekkai D., Collin C., Bout D., and Mévélec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect. Immun. 71 (2003) 6222-6228
17. Jiang T. Study on molecular diagnosis methods and gene immunity for swine toxoplasmosis [D]. Huazhong Agric. Univ. Libr. (2006) 63-65
18. Jiang T., Gong D.H., Ma L.A., Nie H., Zhou Y.Q., Yao B.A., and Zhao J.L. Evaluation of a recombinant MIC3 based latex agglutination test for the rapid serodiagnosis of Toxoplasma gondii infection in swines. Vet. Parasitol. 158 (2008) 51-56
19. Jongert E., Craeye S.D., Dewit J., and Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol. 29 (2007) 445-453
20. Kasper L.H., and Buzoni-Gatel D. Some opportunistic parasitic infections in AIDS: candidiasis, pneumocystosis, cryptosporidiosis, toxoplasmosis. Parasitol. Today 14 (1998) 150-156
21. Kirman J.R., Turon T., Su H., Li A., Kraus C., Polo J.M., Belisle J., Morris S., and Seder R.A. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an Alphavirus Plasmid Replicon Expressing Antigen 85A. Infect. Immun. 71 (2003) 575-579
22. Leitner W.W., Hwang L.N., Deveer M.J., Zhou A., Silverman R.H., Williams B.R., Dubensky T.W., Ying H., and Restifo N.P. Alphavirusbased DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 9 (2003) 33-39
23. Leitner W.W., Ying H., Driver D.A., Dubensky T.W., and Restifo N.P. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Res. 60 (2000) 51-55
24. Liljestrom P., and Garoff H. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (NY) 9 (1991) 56-61
25. Liu Q., Gao S.Y., Jiang L., Shang L.M., Men J.T., Wang Z., Zhai Y.J., Xia Z.P., Hu R.L., Zhang X.C., and Zhu X.Q. A recombinant Pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microb. Infect. 8 (2008) 1-8
26. Mateus-Pinilla N.E., Dubey J.P., Choromanski L., and Weigel R.M. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol. 85 (1999) 855-860
27. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
28. Sun S.Q., Liu X.T., Guo H.C., Yin S.H., Shang Y.J., Feng X., Liu Z.X., and Xie Q.G. Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus. J. Gen. Virol. 88 (2007) 842-848
29. Tentera A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30 (2000) 1217-1258
30. Wang S.P., Fang L.R., Chen H.C., and Xiao S.B. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine 25 (2007) 8220-8227
31. Xiao S.B., Chen H.C., Fang L.R., Liu C.S., Zhang H., and Jiang Y.B. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. Vaccine 22 (2004) 345-351
32. Zhou H.Y., Gu Q.M., Zhao Q.L., Zhang J.Q., Cong H., Li Y., and He S.Y. Toxoplasma gondii expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol. Res. 100 (2007) 829-835